Phenotypic screening in cancer drug discovery — past, present and future
Phenotypic screening in cancer drug discovery — past, present and future
About this item
Full title
Author / Creator
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Key Points
Drug discovery approaches for cancer, as for other therapeutic areas, have typically been divided into two classes: target-based drug discovery (TDD) and phenotypic drug discovery (PDD). Cancer drug discovery poses substantial challenges for both targeted and 'classical' phenotypic drug discovery owing to the number, diversity and pla...
Alternative Titles
Full title
Phenotypic screening in cancer drug discovery — past, present and future
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1551017924
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1551017924
Other Identifiers
ISSN
1474-1776
E-ISSN
1474-1784
DOI
10.1038/nrd4366
